Carnitine palmitoyltransferase II deficiency, myopathic form (Q104470): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Changed an Item
‎Changed an Item
Property / CURIE
 
CID11:ID_93488909
Property / CURIE: CID11:ID_93488909 / rank
 
Normal rank

Revision as of 10:19, 17 August 2026

The myopathic form of carnitine palmitoyltransferase II (CPT II) deficiency, an inherited metabolic disorder that affects mitochondrial oxidation of long chain fatty acids (LCFA), is the most common and the least severe form of CPT II deficiency. The clinical manifestations are characterised by recurrent attacks of rhabdomyolysis, muscle pain, and weakness triggered usually by prolonged physical exercise and sometimes exacerbated by extremes in temperature; episodes may also be provoked or exacerbated by prolonged fasting, such as may occur with intercurrent viral illness.
Language Label Description Also known as
default for all languages
ID_93488909
    English
    Carnitine palmitoyltransferase II deficiency, myopathic form
    The myopathic form of carnitine palmitoyltransferase II (CPT II) deficiency, an inherited metabolic disorder that affects mitochondrial oxidation of long chain fatty acids (LCFA), is the most common and the least severe form of CPT II deficiency. The clinical manifestations are characterised by recurrent attacks of rhabdomyolysis, muscle pain, and weakness triggered usually by prolonged physical exercise and sometimes exacerbated by extremes in temperature; episodes may also be provoked or exacerbated by prolonged fasting, such as may occur with intercurrent viral illness.

      Statements

      CID11:ID_93488909
      0 references